- MeSH
- chybná diagnóza MeSH
- endometrióza * chirurgie diagnostické zobrazování farmakoterapie MeSH
- gynekologické chirurgické výkony metody normy MeSH
- laparoskopie metody normy škodlivé účinky MeSH
- lidé MeSH
- nepoznaná diagnóza MeSH
- opožděná diagnóza MeSH
- pánevní bolest chirurgie etiologie prevence a kontrola MeSH
- pooperační komplikace epidemiologie etiologie MeSH
- ženská infertilita farmakoterapie prevence a kontrola MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- MeSH
- gynekologické chirurgické výkony normy MeSH
- gynekologie normy MeSH
- klinické rozhodování MeSH
- konsensus MeSH
- lidé MeSH
- medicína založená na důkazech normy MeSH
- nádorové biomarkery analýza MeSH
- nádory vaječníků diagnóza MeSH
- nemoci děložních adnex diagnóza MeSH
- předoperační období MeSH
- společnosti lékařské MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Optimizing and ensuring the quality of surgical care is essential to improve the management and outcome of patients with cervical cancer.To develop a list of quality indicators for surgical treatment of cervical cancer that can be used to audit and improve clinical practice. METHODS: Quality indicators were developed using a four-step evaluation process that included a systematic literature search to identify potential quality indicators, in-person meetings of an ad hoc group of international experts, an internal validation process, and external review by a large panel of European clinicians and patient representatives. RESULTS: Fifteen structural, process, and outcome indicators were selected. Using a structured format, each quality indicator has a description specifying what the indicator is measuring. Measurability specifications are also detailed to define how the indicator will be measured in practice. Each indicator has a target which gives practitioners and health administrators a quantitative basis for improving care and organizational processes. DISCUSSION: Implementation of institutional quality assurance programs can improve quality of care, even in high-volume centers. This set of quality indicators from the European Society of Gynaecological Cancer may be a major instrument to improve the quality of surgical treatment of cervical cancer.
- MeSH
- chirurgická onkologie metody normy MeSH
- gynekologické chirurgické výkony metody normy MeSH
- lidé MeSH
- nádory děložního čípku patologie chirurgie MeSH
- směrnice pro lékařskou praxi jako téma MeSH
- ukazatele kvality zdravotní péče MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- MeSH
- dospělí MeSH
- dysplazie děložního hrdla chirurgie MeSH
- gynekologické chirurgické výkony metody normy MeSH
- lidé MeSH
- miniinvazivní chirurgické výkony metody MeSH
- nádory děložního čípku * chirurgie MeSH
- zachování plodnosti metody MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- novinové články MeSH
METHODS: The European Society of Gynaecological Oncology council nominated an international multidisciplinary development group made of practicing clinicians who have demonstrated leadership and interest in the care of ovarian cancer (20 experts across Europe). To ensure that the statements are evidence based, the current literature identified from a systematic search has been reviewed and critically appraised. In the absence of any clear scientific evidence, judgment was based on the professional experience and consensus of the development group (expert agreement). The guidelines are thus based on the best available evidence and expert agreement. Before publication, the guidelines were reviewed by 66 international reviewers independent from the development group including patients representatives. RESULTS: The guidelines cover preoperative workup, specialized multidisciplinary decision making, and surgical management of diagnosed epithelial ovarian, fallopian tube, and peritoneal cancers. The guidelines are also illustrated by algorithms.
OBJECTIVES: The surgical management of advanced ovarian cancer involves complex surgery. Implementation of a quality management program has a major impact on survival. The goal of this work was to develop a list of quality indicators (QIs) for advanced ovarian cancer surgery that can be used to audit and improve the clinical practice. This task has been carried out under the auspices of the European Society of Gynaecologic Oncology (ESGO). METHODS: Quality indicators were based on scientific evidence and/or expert consensus. A 4-step evaluation process included a systematic literature search for the identification of potential QIs and the documentation of scientific evidence, physical meetings of an ad hoc multidisciplinarity International Development Group, an internal validation of the targets and scoring system, and an external review process involving physicians and patients. RESULTS: Ten structural, process, or outcome indicators were selected. Quality indicators 1 to 3 are related to achievement of complete cytoreduction, caseload in the center, training, and experience of the surgeon. Quality indicators 4 to 6 are related to the overall management, including active participation to clinical research, decision-making process within a structured multidisciplinary team, and preoperative workup. Quality indicator 7 addresses the high value of adequate perioperative management. Quality indicators 8 to 10 highlight the need of recording pertinent information relevant to improvement of quality. An ESGO-approved template for the operative report has been designed. Quality indicators were described using a structured format specifying what the indicator is measuring, measurability specifications, and targets. Each QI was associated with a score, and an assessment form was built. CONCLUSIONS: The ESGO quality criteria can be used for self-assessment, for institutional or governmental quality assurance programs, and for the certification of centers. Quality indicators and corresponding targets give practitioners and health administrators a quantitative basis for improving care and organizational processes in the surgical management of advanced ovarian cancer.
- MeSH
- ambulantní péče organizace a řízení trendy MeSH
- chybná zdravotní péče zákonodárství a právo MeSH
- gynekologické chirurgické výkony metody normy trendy MeSH
- gynekologie * metody organizace a řízení pracovní síly výchova zákonodárství a právo MeSH
- kvalita zdravotní péče MeSH
- lidé MeSH
- porodnictví * metody organizace a řízení pracovní síly výchova zákonodárství a právo MeSH
- výsledky a postupy - zhodnocení (zdravotní péče) MeSH
- Check Tag
- lidé MeSH
- MeSH
- adjuvantní chemoterapie metody MeSH
- antitumorózní látky hormonální terapeutické užití MeSH
- antitumorózní látky terapeutické užití MeSH
- biologická terapie metody MeSH
- gynekologické chirurgické výkony normy statistika a číselné údaje MeSH
- imunoterapie trendy MeSH
- inhibitory angiogeneze terapeutické užití MeSH
- lidé MeSH
- monoklonální protilátky terapeutické užití MeSH
- nádory vaječníků * epidemiologie farmakoterapie chirurgie terapie MeSH
- receptory vaskulárního endoteliálního růstového faktoru antagonisté a inhibitory MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
- MeSH
- gynekologické chirurgické výkony normy MeSH
- nádory ženských pohlavních orgánů chirurgie MeSH
- Publikační typ
- rozhovory MeSH
